Cargando…
NAV3 Is a Novel Prognostic Biomarker Affecting the Immune Status of the Tumor Microenvironment in Colorectal Cancer
Colorectal cancer (CRC) is one of the most common malignant tumors in the world. Tumor microenvironment (TME) plays a crucial role in the development of CRC. With the deep understanding of TME function, growing studies have demonstrated that alteration in tumor-infiltrating immune cells (TICs) and g...
Autores principales: | Li, Menglong, Wang, Zhiqiang, Dong, Shuai, Xu, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9262578/ https://www.ncbi.nlm.nih.gov/pubmed/35812247 http://dx.doi.org/10.1155/2022/8337048 |
Ejemplares similares
-
SPARCL1 Is a Novel Prognostic Biomarker and Correlates with Tumor Microenvironment in Colorectal Cancer
por: Zhang, Hai-Ping, et al.
Publicado: (2022) -
TREM1 as a novel prognostic biomarker and tumor immune microenvironment evaluator in glioma
por: Lu, Qin, et al.
Publicado: (2023) -
KNSTRN, a Poor Prognostic Biomarker, Affects the Tumor Immune Microenvironment and Immunotherapy Outcomes in Pan-Cancer
por: Zhang, Wanli, et al.
Publicado: (2023) -
Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of colorectal cancer
por: Li, Wei, et al.
Publicado: (2021) -
HAMP as a Prognostic Biomarker for Colorectal Cancer Based on Tumor Microenvironment Analysis
por: Wei, Fang-Ze, et al.
Publicado: (2022)